GURUFOCUS.COM » STOCK LIST » Asia » China » SZSE » China National Accord Medicines Corp Ltd (SZSE:200028) » Definitions » Net Margin %
Switch to:

China National Accord Medicines (SZSE:200028) Net Margin %

: 2.38% (As of Jun. 2023)
View and export this data going back to 1993. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. China National Accord Medicines's Net Income for the three months ended in Jun. 2023 was HK$512 Mil. China National Accord Medicines's Revenue for the three months ended in Jun. 2023 was HK$21,548 Mil. Therefore, China National Accord Medicines's net margin for the quarter that ended in Jun. 2023 was 2.38%.

The historical rank and industry rank for China National Accord Medicines's Net Margin % or its related term are showing as below:

SZSE:200028' s Net Margin % Range Over the Past 10 Years
Min: 1.96   Med: 2.46   Max: 2.88
Current: 2.17


SZSE:200028's Net Margin % is ranked better than
57.3% of 89 companies
in the Medical Distribution industry
Industry Median: 1.55 vs SZSE:200028: 2.17

China National Accord Medicines Net Margin % Historical Data

The historical data trend for China National Accord Medicines's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.81 2.40 2.35 1.96 2.02

China National Accord Medicines Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.22 2.02 2.33 1.94 2.38

Competitive Comparison

For the Medical Distribution subindustry, China National Accord Medicines's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

China National Accord Medicines Net Margin % Distribution

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Net Margin % distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Net Margin % falls in comparison to its industry or sector. The grey bar indicates the Net Margin %'s extreme value range as defined by GuruFocus.



China National Accord Medicines Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

China National Accord Medicines's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=1660.229/82015.032
=2.02 %

China National Accord Medicines's Net Margin for the quarter that ended in Jun. 2023 is calculated as

Net Margin=Net Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=511.94/21548.258
=2.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China National Accord Medicines  (SZSE:200028) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


China National Accord Medicines Net Margin % Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:200028) Business Description

China National Accord Medicines logo
Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:200028) Headlines

No Headlines